Ki-67 proliferative index predicts progression-free survival of patients with well-differentiated ileal neuroendocrine tumors

Human Pathology

Volumn 43, Issue 4, 2012, Pages 489-495

  Dhall, Deepti ^a   Mertens, Richard ^a   Bresee, Catherine ^b   Parakh, Rugvedita ^a   Wang, Hanlin L ^a   Li, Marissa ^a   Dhall, Girish ^c   Colquhoun, Steven D ^b   Ines, Delma ^a   Chung, Fai ^a   Yu, Run ^b   Nissen, Nicholas N ^b   Wolin, Edward ^d  

^a Cedars Sinai Medical Center   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

^d Samuel Oschin Comprehensive Cancer Institute   (United States)

Author keywords

Carcinoid; Ileum; Ki 67; NET; Neuroendocrine tumor; Prognosis; Progression free survival

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CARCINOID; CELL PROLIFERATION; DISTANT METASTASIS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; ILEUM CANCER; IMAGE ANALYSIS; IMAGING SYSTEM; IMMUNOHISTOCHEMISTRY; KI 67 PROLIFERATIVE INDEX; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MESENTERY; PREDICTIVE VALUE; PRIMARY TUMOR; PROGRESSION FREE SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOID TUMOR; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; ILEAL NEOPLASMS; IMAGE PROCESSING, COMPUTER-ASSISTED; KI-67 ANTIGEN; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MITOTIC INDEX; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84858161345     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.06.011     Document Type: Article

References (20)

1. G. Rindi, C. Azzoni, and S. La Rosa ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis Gastroenterol 116 1999 532 542 (Pubitemid 29106760)
2. K. Hotta, T. Shimoda, Y. Nakanishi, and D. Saito Usefulness of Ki-67 for predicting the metastatic potential of rectal carcinoids Pathol Int 56 2006 591 596 (Pubitemid 44423017)
3. T.N. Moyana, J. Xiang, A. Senthilselvan, and A. Kulaga The spectrum of neuroendocrine differentiation among gastrointestinal carcinoids: importance of histologic grading, MIB-1, P53, and bcl-2 immunoreactivity Arch Pathol Lab Med 124 2000 570 576 (Pubitemid 30210990)
4. A. Chaudhry, K. Oberg, and E. Wilander A study of biological behavior based on the expression of a proliferating antigen in neuroendocrine tumors of the digestive system Tumour Biol 13 1992 27 35
5. J. Strosberg, A. Nasir, D. Coppola, M. Wick, and L. Kvols Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors Hum Pathol 40 2009 1262 1268
6. A.D. Amarapurkar, A. Davies, J.K. Ramage, A.J. Stangou, D.G. Wight, and B.C. Portmann Proliferation of antigen MIB-1 in metastatic carcinoid tumours removed at liver transplantation: relevance to prognosis Eur J Gastroenterol Hepatol 15 2003 139 143 (Pubitemid 36269777)
7. C. Sökmensüer, G. Gedikoglu, and B. Uzunalimoglu Importance of proliferation markers in gastrointestinal carcinoid tumors: a clinicopathologic study Hepatogastroenterology 48 2001 720 723 (Pubitemid 32619669)
8. I.M. Modlin, M.D. Shapiro, M. Kidd, and G. Eick Siegfried Oberndorfer and the evolution of carcinoid disease Arch Surg 142 2007 187 197 (Pubitemid 46294146)
9. M.K. Washington, L.H. Tang, and J. Berlin Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the small intestine and ampulla Arch Pathol Lab Med 134 2010 181 191
10. G. Rindi, R. Arnold, and F.T. Bosman Nomenclature and classification of the neuroendocrine neoplasms of the digestive system F.T. Bosman, F. Carneiro, R.H. Hruban, N.D. Theise, WHO classification of tumours of the digestive system 2010 IARC Press Lyon (France) 13
11. M. Volante, L. Righi, A. Berruti, G. Rindi, and M. Papotti The pathological diagnosis of NETS: common questions and tentative answers Virchows Arch 458 2011 393 402
12. M. Kawahara, M. Kammori, and H. Kanauchi Immunohistochemical prognostic indicators of gastrointestinal carcinoid tumours Eur J Surg Oncol 28 2002 140 146 (Pubitemid 35023655)
13. J.L. Cunningham, L. Grimelius, A. Sundin, S. Agarwal, and E.T. Janson Malignant ileocecal serotonin-producing carcinoid tumors: the presence of a solid growth pattern and/or Ki67 index above 1% identifies patients with a poorer prognosis Acta Oncol 46 2007 747 756 (Pubitemid 47123778)
14. G. Canavese, C. Azzoni, and S. Pizzi p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior Hum Pathol 32 2001 1094 1101 (Pubitemid 33015670)
15. S. Van Eeden, P.F. Quaedvlieg, B.G. Taal, G.J. Offerhaus, C.B. Lamers, and M.L. Van Velthuysen Classification of low-grade neuroendocrine tumors of midgut and unknown origin Hum Pathol 33 2002 1126 1132 (Pubitemid 35416711)
16. S. Rossi, L. Laurino, and A. Furlanetto Rabbit monoclonal antibodies: a comparative study between a novel category of immunoreagents and the corresponding mouse monoclonal antibodies Am J Clin Pathol 124 2005 295 302 (Pubitemid 41060143)
17. C.G. Loukas, G.D. Wilson, B. Vojnovic, and A. Linney An image analysis-based approach for automated counting of cancer cell nuclei in tissue sections Cytometry A 55 2003 30 42 (Pubitemid 37522519)
18. E. Endl, and J. Gerdes The Ki-67 protein: fascinating forms and an unknown function Exp Cell Res 257 2000 231 237 (Pubitemid 30390473)
19. K. Sasaki, T. Murakami, M. Kawasaki, and M. Takahashi The cell cycle associated change of the Ki-67 reactive nuclear antigen expression J Cell Physiol 133 1987 579 584 (Pubitemid 18014270)
20. S.W. Coons, P.C. Johnson, and D.K. Pearl The prognostic significance of Ki-67 labeling indices for oligodendrogliomas Neurosurgery 41 1997 878 884 [discussion 884-5]